Legacy AI grade · Sources dated 2026-06-01. Not expert reviewed. Coverage is limited to the listed sources. About the new summary workflow

Ginger for Osteoarthritis

Verdict: Modest, uncertain help for osteoarthritis pain

Ginger appears to produce a small, statistically real reduction in osteoarthritis pain, but the effect is clinically modest and not consistently confirmed, so it is at best a minor add-on rather than a proven treatment. Stomach upset is common, and no major arthritis guideline recommends it.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

A 2015 meta-analysis of five placebo-controlled trials (n=593, PMID 25300574) found ginger significantly lowered pain (SMD -0.30) and disability (SMD -0.22), but both effects are small, and patients taking ginger were more than twice as likely to quit treatment (RR 2.33), mostly from gastrointestinal upset. Two randomized trials (PMID 11710709; PMID 39212491) reported significant pain relief, but both were industry-funded, tempering their weight.

Critically, a 2020 PRISMA systematic review (PMID 32214292) measured an oral-ginger pain reduction of about 8 mm yet concluded the evidence is insufficient to support ginger over placebo; topical ginger and function outcomes showed no benefit. So the field itself does not regard the case as settled, which is why this lands at Tier B preliminary rather than higher.

Regulators and clinics reinforce caution. EFSA and the WHO treat ginger mainly as a food/anti-nausea agent with no approved osteoarthritis claim, and the NHS endorses it only for morning sickness. Mayo Clinic and the ACR/OARSI rheumatology guidelines do not mention ginger for arthritis at all, while Cleveland Clinic and Harvard note only a mild, diet-oriented possible benefit.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.64
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
78%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.50
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.65
L1 ExamineGlobal benchmark
0.70
L5 Clinical bodiesAuthoritative stance
0.85
Against Mixed Supports
▸View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.641
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 2 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials
PMID: 25300574 2015 統合分析 n = 593
Finding: Ginger significantly reduced pain (SMD -0.30, 95% CI -0.50 to -0.09, p=0.005, I-squared 27%) and disability (SMD -0.22, 95% CI -0.39 to -0.04, p=0.01, I-squared 0%) versus placebo; however patients on ginger were more than twice as likely to discontinue treatment (RR 2.33, 95% CI 1.04 to 5.22, p=0.04).
Effect size: SMD pain -0.30; SMD disability -0.22; discontinuation RR 2.33
View on PubMed
Effectiveness of Ginger on Pain and Function in Knee Osteoarthritis: A PRISMA Systematic Review and Meta-Analysis
PMID: 32214292 2020 統合分析
Finding: Oral ginger versus placebo reduced pain by MD -7.88 mm (95% CI -11.92 to -3.85, p<0.001) but function change was not significant (SMD -1.61, 95% CI -4.30 to -1.09, p=0.24); topical ginger versus standard treatment showed no significant difference. Authors concluded there is insufficient evidence to support oral ginger over placebo for pain relief and function improvement in knee OA.
🟠 Limited quality Effect size: MD pain -7.88 mm (oral); function NS
View on PubMed
Effects of a ginger extract on knee pain in patients with osteoarthritis
PMID: 11710709 2001 RCT (double-blind) n = 247
Finding: Responder rate was higher with ginger than placebo (63% vs 50%, p=0.048); pain after walking 50 feet also improved more with ginger (15.1 mm vs 8.7 mm, p=0.016). Gastrointestinal adverse events were more common with ginger (59 patients vs 21 with placebo), mostly mild.
⚠️ Industry-funded Effect size: Responder rate 63% vs 50%; mostly mild GI side effects more frequent
View on PubMed
Effectiveness and safety of steamed ginger extract on mild osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial
PMID: 39212491 2024 RCT (double-blind) n = 100
Finding: Steamed ginger extract significantly decreased pain VAS, Korean-WOMAC scores and patient global assessment versus placebo in mild knee OA over 12 weeks, with no significant safety concerns observed.
🟠 Limited quality ⚠️ Industry-funded Effect size: Statistically significant reduction in pain VAS and WOMAC vs placebo
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
L4b EU EFSA
Neutral
no concerns for consumers were identified following the use of the additives up to the highest safe level in animal nutrition source↗
L4c UK NHS
Supportive
There are foods and drinks containing ginger which might help you feel less sick. Check with your pharmacist before taking ginger supplements during pregnancy. source↗
L4d TW TFDA / 衛福部
Supportive
中藥材係乾品,如為新鮮產品屬農產品,並不以中藥材管理 source↗
L4e WHO
Neutral
Rhizoma Zingiberis source↗
L5a NIH Office of Dietary Supplements
Cautious
L5c Cleveland Clinic
Supportive
L5d Harvard Health
Supportive
L5e Specialty Society (condition-mapped)
Not addressed
✓PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-osteoarthritis-INT-ginger-001 繁體中文版 →